in the world suffer from chronic nasal congestion
Constant discomfort, pain and difficulty sleeping significantly affect patients’ quality of life
Side effects, limited efficacy and inconvenience are key limitations of available treatments
As a result of suboptimal treatments available, the societal burden of chronic nasal congestion can exceed $10.000 /patient /year
Orlandi et al., International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary (2016)
Wise et al., International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2020)
is a medical device that treats nasal congestion and facial pain using Precisely Modulated Acoustic Energy (PMAE)
is a medical device that treats nasal congestion and facial pain using Precisely Modulated Acoustic Energy (PMAE)
for treatment include populations with highly prevalent ENT disorders
CRS: Chronic rhinosinusitis;
Figures refer to EU4, UK, US and Japan;
for clinical development and IP protected
based on acoustic wave therapy and IP presents major upsides
*Figures refer to EU4, UK, US and Japan
and lean operating model combining internal experience in the life sciences with external experience of international service providers
Chairman & Managing Director